Clinical Trials on Inoperable or Recurrent Breast Cancer
Total 14480 results
-
Eisai Co., Ltd.CompletedInoperable or Recurrent Breast CancerJapan
-
AstraZenecaRecruitingLocally Advanced (Inoperable) or Metastatic Breast CancerUnited States, Spain, Denmark, Korea, Republic of, Germany, Belgium, Vietnam, United Kingdom, France, Japan, Brazil, Canada, China, Malaysia, Taiwan, Thailand, Australia, Turkey, Argentina, India, Poland, Sweden, Italy
-
AstraZenecaCompletedInoperable or Recurrent Rectal CancerTurkey
-
Hoffmann-La RocheRecruitingInoperable, Locally Advanced or Metastatic, ER-positive Breast CancerUnited States, Korea, Republic of, Spain, Australia, Israel
-
Daehwa Pharmaceutical Co., Ltd.CompletedRecurrent or Metastatic Breast CancerUnited States, Czechia
-
Sun Pharma Advanced Research Company LimitedCompletedRecurrent or Metastatic Breast CancerIndia
-
Daehwa Pharmaceutical Co., Ltd.Active, not recruitingRecurrent or Metastatic Breast CancerChina, Korea, Republic of, Serbia, Bulgaria, Hungary
-
Kyowa Kirin Co., Ltd.CompletedAdvanced or Recurrent Breast CancerJapan
-
Cancer Institute and Hospital, Chinese Academy...QuestgenomicsUnknownRecurrent or Metastatic Breast CancerChina
-
AstraZenecaActive, not recruitingLocally Advanced (Inoperable) or Metastatic Breast CancerUnited States, Italy, Spain, Belgium, Hungary, Poland, Canada, France, Germany, Korea, Republic of, Japan, Peru, Russian Federation, United Kingdom, China, Taiwan, Israel, Australia, Argentina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.UnknownAdvanced Recurrent or Metastatic Breast CancerChina
-
Geron CorporationCompletedLocally Recurrent or Metastatic Breast CancerUnited States, Canada
-
Abramson Cancer Center at Penn MedicineRecruitingWomen With Suspected or Confirmed Recurrent Breast CancerUnited States
-
Shanghai JMT-Bio Inc.Not yet recruitingFirst-line Treatment of HER2-positive Recurrent or Metastatic Breast Cancer
-
Novartis PharmaceuticalsTerminatedMetastatic Breast Cancer (MBC) | Inoperable Locally Advanced Breast CancerFrance, Spain
-
Nanogen Pharmaceutical Biotechnology Joint Stock...Vietstar Biomedical Research; MedProve IncCompletedBreast Cancer Recurrent | Breast Cancer Female | Breast Cancer MetastaticVietnam
-
Nanogen Pharmaceutical Biotechnology Joint Stock...Vietstar Biomedical Research; MedProve IncCompletedBreast Cancer Recurrent | Breast Cancer Female | Breast Cancer MetastaticVietnam
-
University of Southern CaliforniaTerminatedRecurrent Breast Cancer | Metastastic Breast CancerUnited States
-
Korean Breast Cancer Study GroupUnknownMetastatic Breast Cancer | Recurrent Breast CancerKorea, Republic of
-
Spexis AGTerminatedMetastatic Breast Cancer | Locally Recurrent Breast CancerSpain, Belgium, United States, United Kingdom, Korea, Republic of, Taiwan, Italy, Russian Federation, Czechia, France, Brazil, Argentina, Ukraine
-
Asan Medical CenterCompletedStage IV Breast Cancer | Recurrent Breast CancerKorea, Republic of
-
Ontario Clinical Oncology Group (OCOG)Canadian Breast Cancer Research Alliance; Ontario Cancer Research NetworkCompletedMetastatic Breast Cancer | Recurrent Breast CancerCanada
-
National Cancer Institute (NCI)CompletedBreast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerCanada
-
Virginia Commonwealth UniversityEli Lilly and Company; BayerTerminatedBreast Cancer | Metastatic Breast Cancer | Recurrent Breast CancerUnited States
-
Sorrento Therapeutics, Inc.CompletedMetastatic Breast Cancer | Locally Recurrent Breast CancerUnited States, Georgia, Moldova, Republic of, Romania, Serbia, Singapore, Ukraine
-
Hospital Clinic of BarcelonaRecruitingReoperative Sentinel Lymph Node Biopsy in Patients With Recurrent Ipsilateral Breast Cancer (RENATA)Recurrent Breast CancerSpain
-
Korean Breast Cancer Study GroupUnknownRecurrent Breast CancerKorea, Republic of
-
NCIC Clinical Trials GroupGlaxoSmithKlineCompletedRecurrent Breast CancerCanada
-
Dana-Farber Cancer InstituteIncyte CorporationCompletedMetastatic Breast Cancer | Recurrent Breast CancerUnited States
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Breast CancerChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingMetastatic Breast Cancer | Advanced Malignancies | Recurrent Breast CancerChina
-
Sun Pharma Advanced Research Company LimitedWithdrawnMetastatic Breast Cancer | Locally Recurrent CancerIndia
-
Puma Biotechnology, Inc.Not yet recruitingMetastatic Breast Cancer | Recurrent Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast CancerUnited States
-
Alaunos TherapeuticsCompletedBreast Cancer Nos Metastatic RecurrentUnited States
-
Stanford UniversityNational Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedBreast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
AmgenCompletedLocally Recurrent and Metastatic Breast Cancer
-
AmgenCompletedLocally Recurrent and Metastatic Breast CancerUnited States, United Kingdom, Denmark, Poland, Belgium, Hungary, Spain, Austria, France, Australia, Netherlands, Finland, India
-
Yonsei UniversityUnknownInoperable or Recurrent or Metastatic Esophageal Squamous CarcinomaKorea, Republic of
-
AmgenCompletedCancer | Breast Cancer | Breast Neoplasms | Metastatic Cancer | Breast Tumors | Solid Tumors | Oncology | Tumors | Metastases | Locally Recurrent and Metastatic Breast CancerUnited States, Belgium, France
-
Eisai Inc.CompletedLocally Recurrent | Metastatic Breast Cancer ( HER2 Negative)United States
-
Memorial Sloan Kettering Cancer CenterCedars-Sinai Medical CenterCompletedLocally Recurrent/Metastatic Triple Negative Breast CancerUnited States
-
Tata Memorial HospitalAll India Institute of Medical Sciences, New Delhi; Shri Siddhivinayak Ganpati... and other collaboratorsActive, not recruiting
-
PfizerRecruitingEGFR Mutation-positive Inoperable or Reccrent NSCLCJapan
-
Centre Leon BerardAmgenRecruitingHER2-positive Breast Cancer | Operable Breast CancerFrance
-
PharmaMatrix Holdings LtdUniversity of AlbertaRecruitingCancer: Recurrent and/or Metastatic Solid TumoursCanada
-
University of WashingtonMerck Sharp & Dohme LLCWithdrawnMetastatic Breast Cancer | Triple Negative Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor NegativeUnited States
-
University of UtahUnited States Department of DefenseRecruitingBreast Cancer RecurrentUnited States
-
ETOP IBCSG Partners FoundationPfizerRecruitingBreast Cancer RecurrentSwitzerland, Italy, France, Spain, Hungary, Austria
-
Odense University HospitalCompletedBreast Cancer RecurrentDenmark